DaVita Inc. (LON: 0I7E)
London
· Delayed Price · Currency is GBP · Price in USD
169.25
+1.76 (1.05%)
Jan 22, 2025, 7:14 PM BST
DaVita Revenue
DaVita had revenue of $3.26B USD in the quarter ending September 30, 2024, with 4.56% growth. This brings the company's revenue in the last twelve months to $12.67B, up 6.34% year-over-year. In the year 2023, DaVita had annual revenue of $12.14B with 4.57% growth.
Revenue (ttm)
$12.67B
Revenue Growth
+6.34%
P/S Ratio
n/a
Revenue / Employee
$180.95K
Employees
70,000
Market Cap
11.22B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
Dec 31, 2019 | 11.39B | -23.67M | -0.21% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
DaVita News
- 7 days ago - DaVita Inc Celebrates 25 Years of Transformative Kidney Care - GuruFocus
- 8 days ago - DaVita Celebrates 25 Years of Exceptional Patient Care, Empowering the Future of Kidney Health - PRNewsWire
- 13 days ago - DaVita Inc (DVA) Activates Emergency Response Amid Southern California Wildfires - GuruFocus
- 13 days ago - DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires - PRNewsWire
- 2 months ago - DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation - Seeking Alpha
- 2 months ago - DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - PRNewsWire
- 2 months ago - DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 - PRNewsWire
- 3 months ago - DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript - Seeking Alpha